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Abstract 
There is no known cure for Multiple Sclerosis (MS), a chronic inflammatory disease 
characterised by demyelination of the central nervous system. Current treatment 
recommendations focus on symptom management. In order to inform 
recommendations there is a need to identify factors that exacerbate MS symptoms. 
Stress has consistently been associated with MS relapse, however few studies have 
examined the impact of stress on other MS symptoms. This study investigated the 
association between various measures of stressful life events and other MS 
symptoms implicated in the progression of the disease, which include anxiety, 
depression, and fatigue. The 236 participants (184 females) with a first clinical 
diagnosis of demyelination participated in annual reviews for five years. Measures of 
stressful life events, anxiety, depression, and fatigue were obtained. As predicted the 
results showed negative, but not positive, stressful events were associated with 
anxiety, depression, and fatigue. Consistent with hypothesis two, an increased 
number of stressful events that were perceived as more severe and had a higher 
readjustment weighting were significantly associated with anxiety and depression. 
More negative events that had a higher readjustment weighting, but not perceived 
severity, were associated with fatigue. Contrary to the third hypothesis, an increased 
duration of negative stressful events were significantly associated with anxiety and 
depression but not fatigue. Overall, these findings indicate negative stressful events, 
but not positive stressful events, are associated with subsequent anxiety, depression, 
and fatigue in people with MS. Importantly various aspects of stress were shown to 
affect anxiety and depression differently to fatigue.    
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Experiencing stress or interpreting events as stressful almost universally has 
negative effects on health (Schneiderman, Ironson, & Siegel, 2008). Multiple 
Sclerosis (MS), a chronic inflammatory disease characterised by demyelination, is 
no exception to these effects. As there is no known cure for MS, current treatment 
recommendations focus on the management of symptoms (Broadley et al., 2014). 
Thus there is a need to identify factors that exacerbate MS symptoms in order to 
inform effective treatment recommendations. Individuals with MS believe stress is 
one of the most common factors that exacerbate their symptoms (Heesen et al., 
2007). The majority of research supports this notion, and the results of these studies 
have shown a consistent association between stressful life events and subsequent 
relapses in MS (Artemiadis, Anagnostouli, & Alexopoulos, 2011; Mohr, Hart, 
Julian, Cox, & Pelletier, 2004). However, relapses are a short-term outcome which 
are not indicative of overall disease progression (Confavreux, Vukusic, Moreau, & 
Adeleine, 2000). Further, there are limited studies that have examined the 
association between stressful life events and other MS symptoms. Therefore, the aim 
of this study was to go beyond the examination of relapses and investigate the 
association between different components of stressful life events (number, severity, 
and duration) and other MS symptoms implicated in the progression of the disease, 
which include anxiety, depression, and fatigue. 
Multiple Sclerosis 
Multiple Sclerosis is a chronic inflammatory disease that is characterised by 
the demyelination of axons of the central nervous system (Compston & Coles, 
2008). Demyelination refers to the process by which the insulating covers or myelin 
sheaths of axons degenerate (Song et al., 2005). This degeneration reduces the 
effectiveness of communication of the nervous system, which results in a range of 
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symptoms. These commonly include muscle weakness or spasms, visual problems, 
fatigue, depression, and anxiety (Compston & Coles, 2008). To be diagnosed with 
MS, an individual generally needs to experience two episodes of demyelination. 
After the first episode of demyelination, approximately 80% of individuals 
experience further episodes and develop MS after 5 years (Weinshenker et al., 1989). 
Within western countries approximately 1 in 1000 people are affected by MS 
(Sadovnick & Ebers, 1993) including more than 22,000 Australians (Palmer et al., 
2013), with recent research indicating the prevalence of the disease is increasing 
(Simpson et al., 2011).  
The progression of MS can take a number of forms. The majority of the MS 
population, 85-90%, experience a relapsing and remitting form (Confavreux et al., 
2000). This progression is characterised by the sudden onset of new symptoms that 
generally remit with time, however some will have a lasting impairment on 
functioning (Compston & Coles, 2008; Hirst et al., 2008). Despite some impairment, 
the level of functioning of individuals with relapsing and remitting MS is generally 
stable for a number of years (Compston & Coles, 2002; Confavreux et al., 2000). 
After a period of 10-15 years, approximately 60% of these individuals will develop 
secondary progressive MS, which is characterised by the gradual decline in 
functioning (Hirst et al., 2008). In contrast, the minority of individuals diagnosed 
with MS, approximately 10-15% experience primary progressive MS (Confavreux et 
al., 2000). This progression course is characterised by a prolonged and gradual 
decline in functioning from disease onset (Compston & Coles, 2008; Mohr et al., 
2004). Currently there is no cure for MS and treatment recommendations focus on 
symptom management (Broadley et al., 2014). This means there is a need to identify 
factors that exacerbate MS symptoms in order to reduce or manage these factors. 
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Stress and Multiple Sclerosis  
Stress is one of the most common factors thought to trigger exacerbations in 
MS symptoms (Heesen et al., 2007). There is no universally accepted definition of 
stress, however a number of different definitions conceptualise it as the cognitive 
and physiological experience of tension (Monroe, 2008). It is believed that stress is 
the result of a complex interplay between various internal and external factors. These 
factors include an individual’s coping mechanisms, cognitive appraisals, resources, 
and importantly the life events they experience (Gunnar & Quevedo, 2007). 
Individuals with MS reportedly believe that stress can negatively affect their 
symptoms and trigger relapse (Brown, Tennant, Dunn, & Pollard, 2005). There is a 
growing body of evidence that supports this association as is highlighted by a 
systematic literature review and meta-analysis (Mohr et al., 2004). In this review, the 
results of thirteen studies each provided support for the notion that stressful life 
events increased an individual’s risk of symptom exacerbation or relapse, and this 
association was clinically significant with a medium-sized effect (d=0.53). More 
recently, Artemiadis et al. (2011) conducted a systematic review that provided 
further support for this association. Based on these findings, it is evident there is a 
consistent association between experiencing a stressful life event and subsequent 
relapse in MS populations. It is important to differentiate between various aspects of 
stressful life events that may mediate this relationship, such as differences between 
positive and negative stressful events, the number of stressful events over a fixed 
time period and the duration of stressful events.  
Positive and negative stressful events & perceived severity of events. 
Potential differences between the effects of positive and negative stressful life events 
on MS symptoms have begun to be explored (Burns, Nawacki, Kwasny, Pelletier, & 
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Mohr, 2014; Mohr et al., 2000). Negative stressful events are generally undesirable 
events that require adaptation and adjustment, whereas positive stressful events are 
considered desirable events that also feature the need for adjustment and thus the 
potential for stress (Burns et al., 2014). For example, the birth of a child may be a 
positive stressful event, as it does require adaptation and adjustment, but at the same 
time has more positive than negative connotations. Unsurprisingly, the results of 
these studies demonstrate that positive and negative stressful events have differing 
effects on MS. While stressful events perceived to be negative have been associated 
with an increased risk of brain lesions, an indicator of MS disease activity, events 
perceived to be positive have not been associated with disease activity (Burns et al., 
2014; Mohr et al., 2000). Similar results have been demonstrated in naturalistic 
studies using relapse and brain lesions as outcomes. The results of one study, 
conducted over a three year period during the war between Israel and Lebanon, 
indicated that individuals with MS experienced significantly more relapses and brain 
lesions during war periods compared to non-war periods (Yamout, Itani, Hourany, 
Sibaii, & Yaghi, 2010). Taken together these results suggest negative stressful 
events, but not positive stressful events, are associated with exacerbations of MS or 
relapse. It is important to note that among this literature there are key differences in 
the way positive and negative events are categorised. In some studies events have 
been categorised based on desirability (Yamout et al., 2010), whereas in others they 
have been categorised based on the individual’s perception of the event (Burns et al., 
2014). 
Number of stressful events. There have been a number of studies that have 
investigated how an increase in the number of stressful events experienced 
influences MS symptoms (Ackerman et al., 2002; Mitsonis et al., 2008; Potagas et 
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al., 2008). The results of these studies are inconsistent, however the majority indicate 
that an increase in the number of stressful events experienced also increases risk of 
relapse. A study conducted by Ackerman et al. (2002) followed a small sample of 
MS participants for one year and found that an increase in the number of stressful 
life events resulted in a significantly greater risk of relapse. The results of another 
four studies also support these findings (Mitsonis et al., 2008; Potagas et al., 2008). 
It must be noted that three of these studies utilised female only samples (Ackerman 
et al., 2002; Mitsonis et al., 2008; Potagas et al., 2008), which prevents 
generalisation of these results. However, similar findings were also evident in 
research utilising large samples of both females and males (Brown et al., 2006a, 
2006b). In contrast, research by Bulijevac et al. (2003) supports the general 
association between stressful events increasing risk of relapse, although did not 
indicate a cumulative effect of the number of events further increasing the risk of 
relapse. Although these results are not conclusive, the majority of studies 
demonstrate that a greater number of stressful events increase the likelihood of a 
subsequent relapse.    
Duration of stressful events. By contrast to the number of events, other 
researchers have examined whether the duration of a stressful event will influence 
the effect on MS. The results of two studies have indicated that acute stressful 
events, lasting less than 6 months are associated with an increased risk of relapse, 
whereas events with a prolonged duration of over 6 months were not significantly 
associated with risk of relapse (Brown et al., 2006a, 2006b). Consistent with these 
findings, the results of other research has demonstrated that individuals were more 
likely to relapse when they experienced stressful events with an acute duration of 
less than 2 weeks, compared to events with a prolonged duration (Ackerman et al., 
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2002). Similarly, the results of a study conducted by Mitsonis et al. (2008) 
demonstrated that events with a duration of up to 2 weeks were associated with an 
increased risk of relapse. It is proposed variations between acute and prolonged 
durations of stressful events may be due to the individual adjusting to the stress over 
time. Thus an event with a prolonged duration may impact the individual less as over 
time the individual has adjusted to the associated stress. Although there is variability 
in the literature with regards to what is considered acute or prolonged duration, it is 
evident that acute event durations of less than 6 months significantly increase the 
risk of relapse.  
Overall Disease Progression 
As is evident from the above literature, there are a large number of studies 
that have investigated the association between stressful life events and MS relapses 
(Ackerman et al., 2002; Artemiadis et al., 2011; Burns et al., 2014; Mitsonis et al., 
2008; Mohr et al., 2004; Potagas et al., 2008). However there are few studies that 
have examined the association between stressful life events and other aspects of MS 
disease course, such as anxiety, depression, and fatigue. Singularly focusing on 
relapses is a limited approach as relapses are a short-term outcome that do not 
significantly influence the irreversible disability progression of MS (Confavreux et 
al., 2000). Therefore, the association between stressful life events and these other 
aspects of MS disease course need to be investigated. Recent research has shown 
that anxiety, depression, and fatigue are highly comorbid among individuals with 
MS (Wood et al., 2012; Simpson et al., 2015). The concurrent presentation of all 
three outcomes occurs in a significant portion of the MS population (Wood et al., 
2012) and is over three times higher than what would be expected under statistical 
independence (Simpson et al., 2015). These results have lead researchers to conclude 
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that anxiety, depression, and fatigue are part of the disease process of MS and not 
merely a consequence of having the disease (Wood et al., 2012; Simpson et al., 
2015). Thus it is important to investigate the effect stress has on these outcome 
factors to extend the findings of previous research.  
Anxiety. Anxiety refers to a negative mood state characterised by excessive 
fear, which is in anticipation of a real or perceived threat (APA, 2013). Anxiety is 
associated with a number of physiological and behavioural symptoms such as muscle 
tension, sweating, hypervigalence, panic, elevated heart rate, safety behaviours, and 
avoidance (APA, 2013). In relation to individuals with MS, research has 
demonstrated that anxiety is highly prevalent. It is estimated to affect 23.5 - 44.5% 
of the MS population (Dahl, Stordal, Lydersen, & Midgard, 2009; Janssens et al., 
2006; Wood et al., 2012). 
Depression. Depression refers to a negative mood state characterised by a 
low mood and diminished interest or pleasure (APA, 2013). It is associated with a 
variety of physical, cognitive, and behaviour symptoms. These include sleep 
irregularities, fatigue, problems with concentration, feelings of worthlessness, as 
well as unintentional weight changes (APA, 2013). Depression is prevalent among 
10 - 41.8% of individuals with MS (Dahl et al., 2009; Janssens et al., 2006; Wood et 
al., 2012). 
Fatigue. Fatigue has been described as the experience of extreme tiredness 
(Krupp, 2003), or the reversible physical and cognitive impairment that results in a 
lack of motivation to complete activities (Mills & Young, 2008). Researchers have 
suggested that fatigue experienced by those with MS is different to fatigue 
experienced by healthy individuals (Krupp, Serafin, & Christodoulou, 2010). MS 
fatigue tends to have a quicker onset, is more persistent, and prevents physical 
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functioning (Krupp et al., 2010). Staggeringly, results have demonstrated that fatigue 
is prevalent among 50-80% of individuals with MS (Lerdal, Celius, Krupp, & Dahl, 
2007; Nagaraj, Taly, Gupta, Prasad, & Christopher, 2013; Wood et al., 2012). 
Rationale, Aims, and Hypotheses 
As previously stated, stress has consistently been associated with 
exacerbations in MS symptoms. To date, the majority of research has singularly 
focused on the association between stressful life events and relapses (Ackerman et 
al., 2002; Artemiadis et al., 2011; Burns et al., 2014; Mitsonis et al., 2008; Mohr et 
al., 2004; Potagas et al., 2008). Relapses are a short-term outcome that are not 
indicative of overall disease progression (Confavreux et al., 2000). Therefore it is 
necessary to explore the association between stress and other MS symptoms that 
have been implicated in the progression of the disease. The current study will 
investigate three of these symptoms, namely anxiety, depression, and fatigue (Wood 
et al., 2012; Simpson et al., 2015). By learning more about the association between 
stress and MS symptoms, this study has the potential to inform treatment 
recommendations and assist those with MS to manage the disease, for example using 
stress management interventions (Kim, 2007; Richardson & Rothstein, 2008; 
Salmon, 2001). Therefore the aim of this study was to build upon previous research 
that has established a relationship between stress and MS relapse and investigate the 
association between various aspects of stressful life events (e.g., number, severity, 
and duration) and other MS symptoms that have been implicated in the progression 
of the disease (e.g., anxiety, depression, and fatigue). As noted above, the results of 
previous research have shown that negative, but not positive, stressful life events are 
associated with MS relapse (Burns et al., 2014; Mohr et al., 2000). Given these 
findings it was hypothesised that negative stressful life events, but not positive 
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stressful life events would be significantly associated with higher levels of anxiety, 
depression and fatigue, as measured by the Hospital Anxiety and Depression Scale 
(HADS; Zigmond & Snaith, 1983) and the Fatigue Severity Scale (FSS; Krupp, 
LaRocca, Muir-Nash, & Steinberg, 1989), respectively. Previous research has also 
shown that a higher number of events (Ackerman et al., 2002), and events with an 
increased severity (Burns et al., 2014) are associated with increased risk of relapse. 
Given these findings, it was hypothesised that an increased number and severity 
(including readjustment weighting) of negative stressful life events (but not positive 
events) would be significantly associated with higher levels of anxiety, depression 
and fatigue, as measured by the Hospital Anxiety and Depression Scale (HADS; 
Zigmond & Snaith, 1983) and the Fatigue Severity Scale (FSS; Krupp et al., 1989), 
respectively. Additionally, the results of previous research have shown acute 
durations of less than 6 months as opposed to prolonged durations of stressful events 
are associated with MS relapse (Brown et al., 2006a; Mitsonis et al., 2008). Given 
these findings, it was hypothesised that acute duration negative stressful life events 
(but not positive stressful life events) would be significantly associated with higher 
levels of anxiety, depression and fatigue, as measured by the HADS (Zigmond & 
Snaith, 1983) and FSS (Krupp et al., 1989), respectively.  
Method 
Participants 
  The sample for this study comprised of 236 (184 females) individuals who 
had a first clinical diagnosis of CNS demyelination and were participating in the 
Ausimmune study (Lucas et al., 2007). At study entry, participants ages’ ranged 
from 18-58 years (M=38.66, SD=9.62). The Ausimmune Study is a multicentre case-
control study, which follows individuals with MS who reside within four regions of 
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Australia. Participants were recruited from Brisbane city, Newcastle city and 
surrounding areas, Geelong city and the Western Districts of Victoria, and Tasmania 
from the 1st of November 2003 to the 31st of December 2006. Participant recruitment 
involved a two-tier notification system that involved neurologists, radiologists and 
other relevant medical professionals practicing in the aforementioned regions. The 
study was conducted over a five-year period from 2003 to 2008.  
Procedure 
 Prior to study commencement, ethics approval was obtained from nine 
regional Human Research Ethics Committees and each participant gave written 
informed consent. In order to be eligible to take part in the study each participant’s 
first demyelinating event, which signifies the onset of MS, needed to be established 
by a neurologist. This neurological assessment occurred during the baseline 
interview, which also involved the completion of questionnaires and a nurse 
examination. Subsequent information was gathered at annual reviews from self-
report questionnaires. These questionnaires included demographic information, such 
as age, sex, and employment status as well as medical information, such as blood 
pressure, and medication use. Measures of stressful life events, anxiety, depression, 
and fatigue were also included in these questionnaires.  
Measures. 
Stressful life events were measured retrospectively at yearly intervals for five 
years using a stress questionnaire modified from the Social Readjustment Rating 
Scale (SRRS; Holmes & Rahe, 1967). The questionnaire is a self-report measure of 
the occurrence, severity, and duration of stressful life events that were experienced 
in the previous 12 months. It consists of 16 standard questions and additional space 
to record other events (see Appendix A). For example, indicate if “you became 
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pregnant or menopausal”, if yes please mark the year and months this event occurred 
and state whether this was generally a good or bad experience. Each stressful event 
was rated on an eleven-point Likert scale ranging from -5 (negative stress) to +5 
(positive stress). From this information individual variables were created for the 
number, severity (including weighting), and duration of both negative and positive 
events that occurred in the 5 years, 12 months, and 6 months prior to the individual’s 
5th year review (see Figure 1). The number of stressful events was calculated for 
each time period by adding the number of reported negative and positive events 
separately. A high score for these measures indicates the individual experienced a 
high number of negative or positive events for that time period. Given differences in 
the literature in how negative and positive events have been categorised the present 
study included measures for the individual’s perception of the event as well as a 
desirability measure (readjustment weighting). The perceived severity of stressful 
life events was calculated for each time period by adding the Likert scale ratings for 
both positive and negative events separately. For example, if a participant 
experienced a negative event they assigned a rating of -4 and another negative event 
they assigned a rating of -5 they would have a severity rating for negative events of 
 -9. Higher scores indicate the individual experienced events with a greater perceived 
severity, which could be either positive or negative. In order to calculate stress 
weightings based on desirability for each time period, the 16 standard questions and 
other events were organised into 33 categories that reflected themes of stressful 
events. Each of these categories was then assigned weightings, which indicate the 
amount of readjustment the event requires. These weightings were originally devised 
by Holmes and Rahe (1967) and later reviewed by Scully, Tosi, and Banning (2000). 
Higher scores indicate the individual experienced events that required a greater 
STRESSFUL LIFE EVENTS AND MS 
 
 
13 
amount of readjustment, which could be either positive or negative. For example the 
death of a family member is assigned a weight of 72.5, whereas moving house is 
assigned a weight of 19 (see Appendix B for a list of categories and assigned score). 
The duration of stressful life events was calculated for each time period by adding 
the duration of positive and negative events separately. Higher scores indicate the 
individual experienced events with a longer duration, which could be either positive 
or negative. 
 
  
Figure 1: Measures of stressful life events.  
 
Outcome Measures. 
  Anxiety and Depression symptoms were measured at the fifth year review 
using the Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983). 
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The HADS is a self-report measure consisting of fourteen items that are statements 
referring to anxiety and depression. Each item is measured on a four-point Likert 
scale ranging from 0 (not at all) to 3 (most of the time), for example ‘I look forward 
with enjoyment to things’ or ‘I feel tense or wound up’. There are seven items that 
form the anxiety subscale and seven items that form the depression subscale, the 
scores for each seven items are added to give HADS-A and HADS-D subscale 
scores. Consistent with previous literature, the cut off point to define the presence of 
anxiety or depression was >7. Research has demonstrated that the HADS is a valid 
psychometric tool for use with MS populations (Honarmand & Feinstein, 2009).  
Fatigue was measured at the fifth year review using the Fatigue Severity 
Scale (FSS; Krupp et al., 1989). The FSS is a self-report measure of fatigue, which 
consists of nine items referring to the severity of fatigue symptoms. Each item is 
measured on a seven-point Likert scale ranging from 1 (disagree) to 7 (agree), for 
example ‘I am easily fatigued’ or ‘fatigue causes frequent problems for me’. Higher 
ratings indicate higher levels of fatigue, the mean score of items produces the FSS 
score. Consistent with previous literature, the cut off point to define the presence of 
fatigue was >5.0, whereas a score of <5.0 indicates minimal or absent fatigue. The 
FSS was originally developed for use with MS populations and research has shown 
that it is a valid and reliable tool (Krupp et al., 1989).    
Other Measures. 
Disability status was measured at baseline, in the second/third year review 
and the fifth year review using the Expanded Disability Status Scale (EDSS; 
Kurtzke, 1983). The EDSS provides a rating of disability that can be monitored for 
changes over time. The overall scores are based on assessment of impairments in 
eight functional systems (FS), which are pyramidal (e.g., difficulty moving limbs), 
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cerebellar (e.g., tremors), brainstem (e.g., speech problems), sensory (e.g., 
numbness), bowel and bladder function (e.g., incontinence), visual function (e.g., 
blurred vision), mental function (e.g., concentration), and other. Higher scores 
indicate a greater level of disability. Ratings on the scale range from no disability or 
minimal signs in one FS (1.0) to death due to MS (10.0).  
Body Mass Index (BMI) was measured at baseline and at the 5th year review. 
BMI is a common measurement used to classify weight. Scores are calculated by 
dividing weight by the square of height in meters (kg/m2). Scores 18.5 are 
considered underweight, scores between 18.5 - 24.9 are classified as normal, scores 
between 25 - 29.9 are classified as overweight, and scores greater than 30 are 
classified as obese (WHO, 2015). 
Design and Data Analysis 
The current study followed a longitudinal survey design with five 
measurement intervals. The number, perceived severity, weighting, and duration of 
both positive and negative stressful life events at separate time intervals were 
predictor variables. There were three outcome variables: anxiety, depression and 
fatigue. All statistical analysis were conducted using STATA version 12.0 
(StataCorp, 2015), with alpha levels set at p < .05. In order to examine the individual 
effects of the different aspects of stressful events on each outcome variable, a series 
of linear regressions were conducted. To obtain both unadjusted and adjusted (for 
control variables) estimates of the effect of each predictor on the various aspects of 
stress, separate linear regressions per predictor were conducted. The unadjusted 
linear regression provides an estimation of the effect of the outcome on the predictor 
variable, whereas an adjusted linear regression provides an estimation of the effect of 
the outcome on the predictor whilst also adjusting for important covariates that are 
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likely to influence the relationship. This analytic method is common in epidemiology 
research and has the advantage of increasing statistical power to detect effects (Kahn 
& Sempos, 1989; Lepage, Lamy, Dedieu, Savy, & Lang, 2015).  
For each outcome measure a series of covariates were tested. Covariates were 
chosen for their known association with MS symptoms based on the results of 
Simpson et al., (2015). For anxiety, these were age, sex, disability (EDSS), and 
unemployment. Surprisingly, none of these variables were shown to be significant 
covariates of the association between the different aspects of negative stressful life 
events and anxiety level. Thus no adjustments were made to anxiety analyses. For 
depression, these were age, sex, disability (EDSS), and unemployment. 
Unemployment was shown to be a significant confounder of the association between 
the different aspects of negative!stressful!events!and!level of depression. For 
fatigue, these were age, sex, disability (EDSS), BMI, hypertension, 
immunomodulatory medications, and unemployment. Hypertension and 
unemployment were shown to be significant covariates of the association between 
the number and weighting of negative stressful events and level of fatigue 
To test hypothesis one that negative (but not positive) stressful life events, 
would be significantly associated with anxiety, depression, and fatigue a series of 
simple linear regressions were conducted in which each outcome measure was 
individually regressed on measures of negative and positive stressful life events. To 
test hypothesis two that an increased number, perceived severity, and weighting of 
negative stressful events would be significantly associated with anxiety, depression, 
and fatigue a series of simple linear regressions were conducted in which each 
outcome measure was individually regressed on the number, severity, and weighting 
measures of stressful life events. To test the third hypothesis that decreased duration 
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of negative stressful life events would be significantly associated with anxiety, 
depression, and fatigue a series of simple linear regressions were conducted in which 
each outcome measure was individually regressed on duration measures.  
Results 
Data Assumptions and Screening 
 Prior to running the analyses, the distribution of the data was examined. The 
outcome measures of anxiety and depression were both skewed, thus in order to 
reduce heteroskedasticity of these measures log transformations were applied, with 
all means and coefficients back-transformed on the originals scales. In addition, 
fatigue was highly skewed subsequently cases that did not report any fatigue were 
removed from further analysis. The measure of fatigue, thus only includes cases that 
reported symptoms of fatigue. Log transformations were applied to the remaining 
cases with means and coefficients back transformed on the original scale.  
Sample Characteristics 
 The characteristics of the sample are presented in Table 1. The majority of 
the sample was female and currently employed, which included full time work, part 
time work, or home duties. At the fifth year review, over half of the sample was 
using immuomodulatory (anti-inflammatory) medications, a quarter of the sample 
was using anti-depressant medications, and a seventh of the sample was using anti-
anxiety medications. Descriptive statistics for the primary and secondary outcome 
measures are presented in Table 2. These results demonstrate at the fifth year review 
participants had a mean anxiety score of 6.60, depression score of 4.14, fatigue score 
of 3.84 and disability score of 1.88.  
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Table 1 
 
Characteristics of Sample at 5th year review 
Measure  n % 
Sex Female 184 78.0 
 Male 52 22.9 
Employment status Employed 193  82.1 
 Unemployed 42  17.9 
Hypertension Yes 77 32.9 
 No 157 67.1 
Anti-anxiety medication Yes 34 14.4 
 No 202 85.6 
Anti-depressant medication Yes 60 25.4 
 No 176 74.6 
Immunomodulatory medication Yes 127 53.8 
 No 109 46.2 
n = 236 
 
Table 2 
 
Descriptive Statistics of Outcome Measures at 5th year review 
Measure n M (SD) 
Age at entry 236 38.66 (9.62) 
Age at fifth year review 236 43.82 (9.58) 
HADS – Anxiety 219 6.60 (3.77) 
HADS – Depression 219 4.14 (3.40) 
FSS 179 4.93 (1.32) 
EDSS 229 1.88 (1.64) 
BMI 236 27.60 (5.75) 
 
Stressful Life Events 
Descriptive statistics for measures of negative and positive stressful life 
events are presented in Table 3. For stressful life events that occurred in the previous 
5 years, participants reported experiencing negative events in higher numbers 
compared to positive events. Negative stressful events were also perceived to be 
more severe, have a greater readjustment weighting and a longer duration compared 
to positive stressful events.  
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Table 3 
 
Descriptive Statistics of Stressful Life Events in past 5 years 
Stress Measures Negative events M (SD) 
Positive events 
M (SD) 
Total  
M (SD) 
Number  3.87 (3.24) 2.94 (2.86) 7.59 (4.92)  
Severity  13.72 (14.84) 11.82 (11.58) -* 
Weighting  164.04 (141.36) 63.41 (62.48) 250.60 (164.35) 
Duration of events  168.46 (249.34) 97.08 (104.52) 292.90 (282.80) 
(n=191) stress data for 191 individuals  
*severity scale included zero (neutral severity) no variable created for total severity 
 
Associations Between Stressful Life Events and Level of Anxiety 
Table 4 shows the results of the series of linear regressions between the 
different aspects of negative and positive stressful life events and anxiety. Consistent 
with hypothesis one, measures of negative, but not positive stressful life events were 
significantly associated with anxiety. Also consistent with hypothesis two, increases 
in the number, perceived severity and weighting (readjustment score) of negative 
stressful life events were significantly associated with anxiety level. Interestingly, 
these associations were evident for negative stressful events that occurred in the 
previous 5 years, 12 months, and 6 months. Contrary to the assumptions in the third 
hypothesis, the results demonstrate that both prolonged (12 months and 5 years) and 
acute (6 months) duration measures were significantly associated with anxiety level.  
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Table 4 
 
Effects of Different Indicators and Intervals of Stressful Life Events on Anxiety 
Stress Measure  Unadjusted 
B  SE B 
Number 5 years Total 0.20** 0.06 
  Negative 0.40*** 0.09 
  Positive 0.05 0.11 
 12 months Total 0.30 0.16 
  Negative 0.55** 0.21 
  Positive 0.11 0.28 
 6 months Total 0.38 0.25 
  Negative  0.70*  0.30 
  Positive 0.13 0.43 
Severity 5 years Negative -0.09*** 0.02 
  Positive 0.00 0.03 
 12 months Negative -0.18** 0.06 
  Positive 0.02 0.06 
 6 months Negative -0.23** 0.08 
  Positive 0.03 0.10 
Weighting 5 years Total 0.01*** 0.01 
  Negative 0.01*** 0.00 
  Positive 0.00 0.00 
 12 months Total 0.01* 0.00 
  Negative 0.01** 0.00 
  Positive 0.01 0.01 
 6 months Total 0.01* 0.00 
  Negative  0.02** 0.00 
  Positive 0.01 0.012 
Duration 5 years Total 0.00** 0.00 
  Negative 0.00** 0.00 
  Positive 0.00 0.00 
 12 months Total 0.01* 0.00 
  Negative 0.02** 0.01 
  Positive 0.01 0.01 
 6 months Total 0.01 0.01 
  Negative  0.02* 0.01 
  Positive 0.00 0.01 
Note *p < .05. ** p <.01. *** p < .001.  
 
 
Associations Between Stressful Life Events and Level of Depression 
The unadjusted and adjusted coefficients for the series of linear regressions 
between aspects of stressful life events and depression are presented in Table 5. As 
predicted in hypothesis one, measures of negative, but not positive stressful life 
events were significantly associated with depression. Also consistent with hypothesis 
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two, increases in the number, severity and weighting of negative stressful life events 
were significantly associated with depression level. These results were evident for 
negative stressful events that occurred in the previous 5 years, but interestingly not 
for 12 months, and 6 months. Contrary with the third hypothesis, the results suggest 
that prolonged duration of negative events (over 5 years) were significantly 
associated with depression level, however there were no significant associations 
between acute durations of negative events (that occurred in the previous 12 months 
and 6 months) and depression. The results in Table 5 show these associations 
persisted after adjusting for employment.  
Associations Between Stressful Life Events and Level of Fatigue 
The unadjusted and adjusted coefficients for the series of linear regressions 
between aspects of stressful life events and fatigue are presented in Table 6.  
Consistent with hypothesis one, measures of negative, but not positive stressful life 
events were significantly associated with fatigue. Consistent with hypothesis two, 
the results show that measures of the number and weighting of negative stressful life 
events were significantly associated with level of fatigue. These associations were 
evident for negative stressful events that occurred in the previous 5 years, but 
interestingly not for 12 months, and 6 months. Contrary to the initial hypothesis, no 
significant associations were evident between the perceived severity of negative 
stressful life events and level of fatigue. The results showed no significant 
associations between the duration of negative stressful events and level of fatigue, 
which was inconsistent with the predicted effect in hypothesis three. These 
associations persisted after adjusting for hypertension and employment.  
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Table 5 
 
Effects of Different Indicators and Intervals of Stressful Life Events on Depression 
Stress Measure  Unadjusted Adjusteda 
B  SE B B  SE B 
Number 5 years Total 0.03 0.06 0.03 0.05 
  Negative 0.21* 0.08 0.17* 0.08 
  Positive -0.12 0.09 -0.07 0.09 
 12 months Total -0.01 0.14 -0.00 0.13 
  Negative 0.25 0.19 0.13 0.18 
  Positive -0.32 0.23 -0.18 0.22 
 6 months Total -0.03 0.21 0.01 0.20 
  Negative  0.18 0.27 0.12 0.25 
  Positive -0.34 0.34 -0.22 0.34 
Severity 5 years Negative 0.04** 0.02 0.00* 0.01 
  Positive -0.02 0.02 -0.02 0.02 
 12 months Negative -0.09 0.05 -0.05 0.05 
  Positive -0.07 0.05 -0.04 0.05 
 6 months Negative -0.09 0.07 -0.07 0.07 
  Positive -0.08 0.09 -0.07 0.08 
Weighting 5 years Total 0.00 0.00 0.00 0.00 
  Negative 0.01** 0.01 0.04* 0.02 
  Positive -0.00 0.00 -0.00 0.00 
 12 months Total 0.00 0.00 0.00 0.00 
  Negative 0.00 0.00 0.00 0.00 
  Positive -0.01 0.01 -0.00 0.01 
 6 months Total 0.00 0.00 0.00 0.00 
  Negative  0.00 0.00 0.00 0.00 
  Positive -0.01 0.02 -0.01 0.02 
Duration 5 years Total 0.00 0.00 0.00 0.00 
  Negative 0.00* 0.00 0.00 0.00 
  Positive -0.00 0.00 -0.00 0.00 
 12 months Total 0.00 0.00 0.00 0.00 
  Negative 0.01 0.00 0.01 0.00 
  Positive -0.01 0.01 -0.01 0.01 
 6 months Total -0.00 0.00 0.00 0.00 
  Negative  0.01 0.01 0.00 0.01 
  Positive -0.01 0.01 -0.01 0.01 
Note *p < .05. ** p <.01. *** p < .001.  
a Adjusted for the effect of employment 
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Table 6 
 
Effects of Different Indicators and Intervals of Stressful Life Events on Fatigue 
Stress Measure  Unadjusted Adjusteda 
B  SE B B  SE B 
Number 5 years Total 0.04 0.02 0.04 0.02 
  Negative 0.09** 0.03 0.07* 0.03 
  Positive -0.00 0.01 0.01 0.03 
 12 months Total 0.03 0.06 0.04 0.05 
  Negative 0.07  0.07 0.07 0.07 
  Positive 0.01 0.09 0.03 0.09 
 6 months Total 0.04 0.09 0.04 0.08 
  Negative  0.10  0.10 0.09 0.09 
  Positive 0.06 0.15 0.05 0.14 
Severity 5 years Negative -0.01 0.01 -0.02 0.01 
  Positive -0.00 0.01 -0.00 0.01 
 12 months Negative -0.02 0.02 -0.02 0.02 
  Positive -0.00 0.02 0.00 0.02 
 6 months Negative -0.03 0.03 -0.03 0.03 
  Positive 0.01 0.03 0.00 0.03 
Weighting 5 years Total 0.01* 0.00 0.00 0.00 
  Negative 0.01** 0.00 0.01* 0.00 
  Positive 0.00 0.00 0.00 0.00 
 12 months Total 0.00 0.00 0.00 0.00 
  Negative 0.00 0.00 0.00 0.00 
  Positive 0.00 0.01 0.00 0.00 
 6 months Total 0.00 0.00 0.00 0.00 
  Negative  0.00 0.00 0.00 0.00 
  Positive 0.00 0.02 0.00 0.00 
Duration 5 years Total 0.00 0.00 0.00 0.00 
  Negative 0.00 0.00 0.00 0.00 
  Positive -0.00 0.00 0.00 0.00 
 12 months Total 0.00 0.00 0.00 0.00 
  Negative 0.00 0.00 0.00 0.00 
  Positive -0.00 0.01 0.00 0.00 
 6 months Total 0.00 0.00 0.00 0.00 
  Negative  0.00 0.00 0.00 0.00 
  Positive 0.00 0.01 0.00 0.00 
Note *p < .05. ** p <.01. *** p < .001.  
a Adjusted for the effect of hypertension and employment 
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Discussion 
The aim of the current study was to build upon previous research that has 
established a relationship between stress and MS relapse and investigate whether 
stress is also associated with other MS symptoms that have been implicated in the 
progression of the disease. Specifically, the associations between various aspects of 
stressful life events and anxiety, depression, and fatigue were investigated. As stress 
is not a uniform experience, different indicators were examined, namely the number 
of stressful events, the individual’s perception of the events, a readjustment 
weighting of events, and event duration. The results of the study provided support 
for the initial hypothesis that negative stressful events (undesirable events that 
feature stress), but not positive stressful events (desirable events that also feature 
stress) would be associated with anxiety, depression, and fatigue. In addition, partial 
support was provided for the second and third hypotheses that an increased number, 
severity, and more heavily weighted negative events would be associated with 
anxiety, depression, and fatigue, and that a decreased duration of negative events 
would be associated with anxiety, depression, and fatigue, respectively. Taken 
together the results provide initial evidence that experiencing negative stressful life 
events is associated with the MS symptoms of anxiety, depression, and fatigue, but 
they also suggest that various aspects of stressful events affect these symptoms 
differently.  
Hypothesis One: Negative and Positive Stress 
 As previously mentioned, the results of the study provided support for the 
initial hypothesis that negative stressful events (undesirable events that feature 
stress), but not positive stressful events (desirable events that feature stress) would 
be significantly associated with anxiety, depression, and fatigue – it was found that 
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measures of negative stressful events were significantly associated with subsequent 
levels of anxiety, depression, and fatigue. Further, there were no associations 
between measures of positive stressful events and the outcomes. This pattern of 
results is consistent with previous research in this area, which has indicated 
associations between negative (but not positive) stressful events and exacerbations of 
MS or relapse (Burns et al., 2014; Mohr et al., 2000). The current finding adds to the 
MS literature as it extends the association between stress and relapse to anxiety, 
depression, and fatigue, additional MS symptoms that have been implicated in the 
progression of the disease, but not yet examined. The current finding also adds to 
research in the general population that has demonstrated negative stress increases the 
risk of adverse health outcomes (Cohen et al., 2012; Cohen, Tyrrell, & Smith, 1993).   
Interestingly, the results also show differential temporal effects: Only long-
term negative events (those that occurred in the previous 5 years) were associated 
with depression, but those in the past 12 months and 6 months were not. In contrast, 
anxiety was predicted by negative events that had occurred over all measurement 
points. This in interesting as it indicates experiencing a negative stressful event has a 
more sudden impact on anxiety compared to depression. This finding is consistent 
with previous research that has demonstrated that the onset of anxiety often 
precipitates the onset of depression (Mathew, Pettit, Lewinsohn, Seeley, & Roberts, 
2011; Starr & Davila, 2012). A recently proposed model of comorbid anxiety and 
depression, the diathesis anxiety model (Cohen, Young, Gibb, Hankin, & Abela, 
2014), purports that anxiety leads to depression when an individual exhibits a 
cognitive vulnerability to rumination and self-criticism. The model proposes that as 
an individual’s anxiety level increases, the use of maladaptive coping mechanisms 
(rumination and self-criticism) also increase. Over time these coping mechanisms 
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lead to depressive symptoms. In the present sample it is possible that as an individual 
experienced stressful events, their anxiety level increased acutely. Over time the use 
of maladaptive coping mechanisms may have then led to increased depressive 
symptoms. Alternatively, when an individual experienced a stressful event that leads 
to anxiety, the increases in anxiety may have also led the individual to avoid 
activities. This avoidance may have then over time led to increases in levels of 
depression (Ferster, 1973; Markowitz, 2003). 
Hypothesis Two: Number, Severity, & Weighting of Stress 
The results provided partial support for the second hypothesis that qualitative 
and quantitative aspects of stressful life events - increased number, severity 
(perception of event), and weighting (readjustment score of event) of negative 
stressful events would be significantly associated with anxiety, depression, and 
fatigue. As predicted, increases in these aspects of negative events were associated 
with anxiety and depression, however a different pattern was evident for fatigue. 
Increased number and readjustment weighting of negative events were associated 
with fatigue, yet the perceived severity of negative events was not. These results 
indicate that experiencing more negative stressful life events that are perceived to be 
more severe, and have a higher level of readjustment (weighting) are associated with 
an increase in subsequent levels of anxiety and depression in those with MS. 
Experiencing more negative stressful life events that require a higher level of 
readjustment are also associated with subsequent levels of fatigue. Surprisingly, the 
individual’s perception of the severity of negative events was not associated with 
subsequent fatigue. This last finding was unexpected, however it might be related to 
individual differences in Health Locus of Control (HLC) or the perception of control 
an individual has regarding their illness (Wallston, 2001; Wallston, Wallston, & 
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DeVellis, 1978). HLC is considered to be on a continuum from internal to external. 
Those with an internal locus of control believe that they have the means to control 
their health, whereas those with an external locus of control believe external factors 
control their health. External locus of control has two components, the individual’s 
perception that powerful others (e.g., doctors) control their health (PHLC) and the 
perception that chance or fate control health (CHLC; Wallston, 2001; Wallston et 
al., 1978). In general, external locus of control is associated with poorer outcomes 
(Gale, Batty, & Deary, 2008), however differences are also evident between the two 
components of external locus of control. CHLC has been associated with higher 
levels of anxiety and depression (Brosschot, Gebhardt, & Godaert, 1994), whereas 
PHLC has been associated with higher levels of fatigue (Ray, Jefferies, & Weir, 
1997). This indicates that whether an individual perceives powerful others or 
perceives chance to control their health has varying effects on mental compared to 
physical outcomes. Therefore the finding of no association between an individual’s 
perception of severity of stressful events and fatigue may be due to underlying 
differences of HLC in the sample. Specifically, the sample may have exhibited 
higher perceptions that chance controls their MS (CHLC), which in turn might be 
associated with anxiety and depression but not fatigue. Additionally, an individual’s 
health locus on control may also be related to how they perceive a stressful event. If 
an individual perceives chance to control their MS then they may also perceive 
chance to control the stressful event, which may result in higher levels of stress, and 
accordingly higher anxiety and depression, but not fatigue. 
Aside from this one unexpected result the remaining results are as 
hypothesised and consistent with previous research. Specifically, previous studies 
have found that a greater number of negative stress events and events perceived to be 
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negative are significantly associated with MS relapse (Ackerman et al., 2002; Brown 
et al., 2006a, 2006b; Mitsonis et al., 2008; Potagas et al., 2008). The results of the 
current study extend these findings to other symptoms of MS implicated in the 
progression of the disease. The previous and current findings show that increases in 
the number of events, the individual’s perception of the event’s severity, and the 
level of readjustment of negative events are not only associated with relapse but also 
with increased anxiety, depression, and fatigue. This indicates experiencing 
increases in these aspects of negative stressful events may influence MS disease 
progression.  
Hypothesis Three: Duration of Stressful Events 
The results of this study provided partial support for hypothesis three that 
negative events with an acute duration (less than 6 months) would be associated with 
anxiety, depression, and fatigue. The results demonstrate that the duration of 
negative events that occurred in the previous 5 years, 12 months and 6 months were 
all significantly associated with anxiety. The duration of negative events that 
occurred in the previous 5 years, but not 12 months and 6 months, was significantly 
associated with depression. In addition, the results indicated there was no significant 
association between duration of negative events and fatigue. These findings are 
inconsistent with previous research in which stressful events with an acute duration 
were association with relapse (Ackerman et al., 2002; Brown et al., 2006a, 2006b; 
Mitsonis et al., 2008). The inconsistency between these results may be due to 
methodological differences between previous research and the current study.  
The present study’s finding of variations in the effect of the duration of the 
different outcomes can also be explained in terms of the diathesis anxiety model 
(Cohen et al., 2014). As previously mentioned, the model proposes that as anxiety 
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levels increase the use of maladaptive coping mechanisms (rumination and self-
criticism) also increase. The use of these coping mechanisms over time leads to 
depressive symptoms. Thus in the present study experiencing negative stressful life 
events had an almost immediate impact on anxiety, however over time (and longer 
durations) experiencing stressful life events may have led to maladaptive coping 
mechanisms, which in turn led to depressive symptoms. The finding of no 
association between duration of negative events and fatigue can also be explained in 
terms of HLC. As discussed, the perception that chance or fate control heath has 
been associated with anxiety and depression (Brosschot et al., 1994), whereas the 
perception that powerful others (e.g., doctors) control health has been associated 
with fatigue (Ray et al., 1997). Again the sample may have exhibited higher 
perceptions that chance controls MS (CHLC), which has been associated with 
anxiety and depression but not fatigue. Alternatively, the perception of event 
duration may be more important that the absolute event duration. Therefore if an 
individual perceives chance to control their MS this may mean they also perceive 
chance to control the duration of the stressful event, which may result in anxiety and 
depression, but not fatigue.  
To summarise, the results of this study indicate experiencing negative 
stressful events but not positive stressful events are associated with anxiety, 
depression, and fatigue. Further, experiencing more negative events, that are 
perceived to be more severe, have a greater readjustment rating, and are of longer 
duration are all associated with experiencing anxiety and depression in individuals 
with MS. In addition, experiencing more negative events, that have a greater 
readjustment rating was associated with fatigue, however the perception of severity 
and the duration of negative events was not associated with fatigue.  
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Limitations and Directions for Future Research 
There are several strengths of the present study, including a longitudinal 
repeated measures design, the measurement of numerous covariates, and the 
statistical adjustment of these covariates. However, there are also several limitations 
that need to be considered when interpreting the current results. Firstly, anxiety, 
depression, and fatigue were only included as measures at the fifth year review. This 
means that the effect of stressful events over the five years could only be compared 
to participant’s fifth year anxiety, depression, and fatigue levels. Including these 
measures at the same intervals as stress measurement would allow for more detailed 
examination of the temporal relationship between stress and these variables. 
Secondly, stressful life events were measured retrospectively using a self-report 
questionnaire, which has a number of limits. Research has shown that retrospective 
reporting is prone to recall errors (Dohrenwend, 2006) and that individuals are 
generally better able to recall severe events compared to mild events (Hardt & 
Rutter, 2004). Therefore severe life events (e.g., a family death) may have been more 
accurately recalled than mild life events (e.g., relationship issues). Self-report 
measures are also prone to misinterpretation as question interpretation is based on 
one’s life experiences as well as their literacy level. This means that for different 
individuals the event referred to in the questionnaire may constitute a range of 
different meanings (Dohrenwend, 2006). This suggests the stressful event data may 
not be truly representative of the events that actually occurred. Additionally, the data 
was analysed using a series of linear regressions whereas implementing multiple 
regressions would have allowed the identification of which stressful life event 
aspects (number, severity, weighting, or duration) has the greatest influence on the 
outcome measures. Although using multiple regressions would have led to 
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interesting results the use of linear regressions was chosen in order to statistically 
adjust for known covariates of symptoms of MS. The current method is imperative 
as it results in a more power analysis.  
Future research should aim to replicate the findings of this study while 
overcoming the aforementioned limitations. To overcome the limitations of self-
report measures, interview based reports are considered the best practice in assessing 
stressful life events (Dohrenwend, 2006). In the present study, the stress 
questionnaire was implemented in an interview based format at the fourth year 
review, however due to time and financial constraints this format was unable to be 
implemented at each of the five reviews. In future research, interview based 
measures of stress should be utilised where possible. Future research should also aim 
to measure anxiety, depression, and fatigue at the same intervals as stress 
measurement and include multiple regression with various aspects of stress as part of 
the data analysis.    
Implications  
The finding that negative stressful events are associated with anxiety, 
depression, and fatigue in people with a first CDE has important implications for the 
wider MS population. There are a number of stress management interventions that 
have been shown to reduce the negative effects of stress (Kim, 2007; Richardson & 
Rothstein, 2008; Salmon, 2001). Utilising such interventions in the MS population 
may thus reduce the severity of anxiety, depression, and fatigue, which in turn may 
positively influence the progression of the disease. Treating clinicians are 
encouraged to provide education about stress and integrate stress management 
interventions into treatment recommendations. Cognitive behavioural therapy (CBT) 
is one psychological intervention that has been shown to be effective for the 
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treatment of stress (Kim, 2007; Richardson & Rothstein, 2008), as well as anxiety 
(Hoffman & Smits, 2008), depression (Tolin, 2010), and fatigue (Malouff, 
Thorsteinsson, Rooke, Bhullar, & Schutte, 2008; Price, Mitchell, Tidy, & Hunnot, 
2008). CBT involves challenging and modifying maladaptive cognitions and 
behaviours that are believed to maintain the disorder or negative mental state. There 
is emerging evidence that CBT is an effective treatment for symptoms of anxiety, 
depression, distress, fatigue, and pain in the MS population (Thomas, Thomas, 
Hillier, Galvin, & Baker, 2006). Therefore CBT could be recommended as a stress 
management intervention for MS populations. An alternative stress management 
intervention is physical exercise. Exercise is increasingly being used and 
recommended for the treatment of stress (Pederson & Saltin, 2006; Salmon, 2001). 
The results of longitudinal studies have demonstrated that aerobic exercise has 
protective effects against stress, as well as anxiety and depression (Salmon, 2001). 
Similar protective effects of exercise have been demonstrated in MS populations 
(Pederson & Saltin, 2006).  
The finding that positive stressful events are not associated with anxiety, 
depression, and fatigue in people with MS needs to be communicated to individuals 
with the disease. This information provides greater certainty about what factors do 
and do not influence MS symptoms and enables individuals to manage the disease. 
Greater certainty of these factors may in turn reduce psychological distress, which is 
common in those with MS (Janssens et al., 2006). In summary, the results of the 
present study show that negative stressful events are associated with anxiety, 
depression, and fatigue. This suggests using interventions that target stress, such as 
CBT or exercise, may reduce the severity of the associated symptoms, which in turn 
may positively affect MS disease progression. The results also show positive 
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stressful events are not associated with anxiety, depression, and fatigue. It is hoped 
this finding will provide greater certainty as to the factors that do and do not affect 
MS symptoms.  
Conclusions 
  This five year longitudinal study expands previous research on the effect of 
stressful life events in those with MS as it incorporates symptoms that have been 
implicated in the overall progression of the disease, which were anxiety, depression, 
and fatigue. The results of this study led to several important conclusions. Firstly, 
negative stressful events, but not positive stressful events, impact subsequent levels 
of anxiety, depression, and fatigue in MS populations. Secondly, it was shown that 
individual aspects of negative stressful events affect anxiety and depression 
differently to fatigue. Specifically, increases in each individual aspect of negative 
stress (number, severity, readjustment weighting, and duration) were associated with 
anxiety and depression. However, increases in number and readjustment weighting 
of negative events were associated with fatigue, but the individual’s perception of 
severity and duration of negative events were not associated with fatigue. The results 
of the study indicate the importance of integrating stress management interventions 
into MS treatment recommendations. As it is anticipated reducing the effects of 
negative stress will positively influence the progression of the disease. Further, 
treating clinicians are encouraged to provide education about the impact of both 
negative and positive stress as it is anticipated this will provide individuals with MS 
greater certainty about the factors that influence their symptoms. Future research 
should aim to replicate these findings while overcoming the limitations of the 
present study. Overall, this study indicates that the experience of negative stress is 
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not only associated with MS relapses, but is also associated with symptoms 
implicated in the progression of the disease. 
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Appendix B 
Table A7 
Weighting of Stressful Life Event Categories based on Scully et al. (2000)  
Stressful life event 
category 
Holmes and Rahe; and Scully et 
al. categories 
Scully et 
al. weights 
Final 
weight 
 
Family death 
 
Death of a spouse 
 
100 
 
72.5*  
 Death of a close family member 45  
Relative death  Death of a close family member 45 45 
Participant illness Personal injury of illness 57 57 
Participant injury Personal injury of illness 57 57 
Friend injury  Change in health of family 
member 
46 46 
Participant 
breakup/issues 
Divorce 
Marital separation 
Change in number or arguments 
with spouse 
 
58 
51 
26 
45* 
Participant pregnant Pregnancy 27 27 
Participant married Marriage 50 50 
Participant police Minor violation with the law 15 15 
Participant fired or 
expelled 
Fired at work 34 34 
Participant crisis  - - 55** 
New family member Gain of new family member 21 21 
Financial crisis - - 50** 
Changed house Change in residence 19 19 
Changed health 
habits 
Revision of personal habits 
Change in sleeping habits 
Change in eating habits 
13 
17 
13 
14.3* 
Personal 
achievement 
Outstanding personal 
achievement  
23 23 
Change in work  Retirement 
Change to different line of work 
Change in responsibilities at 
work 
Change in work hours or 
conditions  
18 
30 
21 
25 
 
23.5 
Work or school 
stress 
Begin or end school 
Change in schools 
Trouble with boss 
21 
18 
22 
20.3* 
Family member with - - 46** 
 
 
 
58 
problems 
Family member 
illness 
Change in health of family 
member 
46 46 
Friend illness Change in health of family 
member 
46 46 
Participant medical 
procedure 
Personal illness of injury  57 57 
Pregnancy issues 
and related 
Pregnancy  40 40 
Relationship 
problems with 
family  
Trouble with in-laws 11 11 
Family member with 
new relationship 
Gain of new family member 21 21 
Participant travelled Vacation 13 13 
Family travel or 
moved 
Son or daughter leaving home  18 18 
Major project or 
event (mostly 
renovations) 
Change in living conditions  26 26 
Financial related  Change in financial state 
Foreclosure of mortgage or loan 
43 
36 
39.5* 
Legal or business 
related  
Business readjustment 
Minor violations with the law 
Jail term 
12 
15 
50 
25.5* 
Social Change in social activities 21 21 
Family visit stress Change in number of family get-
togethers 
21 21 
Note:  
* final weightings are based on the average weighting of multiple Holmes and Rahe categories.  
** final weightings are the result of a comparison to similar Holmes and Rahe categories.  !
